Stock Detail
Videos
Aytu BioPharma (AYTU) Fireside Chat
Aytu BioPharma (Nasdaq: AYTU) is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients. This fireside chat was recorded during the Lytham Partners 2026 Investor...
Aytu BioPharma (AYTU) Company Webcast
Aytu BioPharma (Nasdaq: AYTU) is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients. This company webcast was recorded during the Lytham Partners Fall 2025 Investor...
Aytu BioPharma (AYTU) Fireside Chat
During this fireside chat we welcome Aytu BioPharma (Nasdaq: AYTU). Aytu is a pharmaceutical company focused on commercializing novel therapeutics. This fireside chat was recorded during the Lytham Partners 2025 Investor Healthcare Summit.
News
Aytu BioPharma Reports Fiscal 2026 Second Quarter Operational and Financial Results
Total net revenue of $15.2 millionAdjusted EBITDA1 of $(0.8) million, which includes EXXUA launch investments$30.0 million cash balance at December 31, 2025Company launched EXXUA™ (gepirone) extended-release tablets ("EXXUA") in December 2025 as the centerpiece...
Aytu BioPharma to Report Fiscal 2026 Second Quarter Operational and Financial Results on February 3, 2026
DENVER, CO / ACCESS Newswire / January 27, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients,...
Aytu BioPharma Recaps Investor Day Held on January 20, 2026
DENVER, CO / ACCESS Newswire / January 20, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients,...